Tag: COVID-19
FDA Action Expands Access to Medication Abortion
FDA permanently removes in-person dispensing requirement for mifepristone and allows retail and online pharmacies to directly provide medication to patients.
Impact of the COVID-19 Pandemic on Sexual and Reproductive Health Services in Burkina Faso, Ethiopia, Kenya, Malawi and Uganda
This report by the Center for Reproductive Rights, the African Population and Health Research Center, and partners reveals that women and girls from low-income backgrounds in five African countries faced multiple barriers in accessing sexual and reproductive health (SRH) services at the onset of the COVID-19 pandemic. These barriers resulted in a spike of unintended pregnancies, […]
2021 EU-NGO Human Rights Forum to Feature Center Executives
2021 EU-NGO Human Rights Forum to feature executives from the Center for Reproductive Rights.
Front Lines E-newsletter: News From the Global Fight for Reproductive Rights
The Center for Reproductive Rights issued a new edition of its monthly newsletter, Front Lines, with the latest updates on the Center’s work in Africa, Asia, Europe, Latin America and the Caribbean, and the United States. In this month’s issue, you’ll learn about the Center’s recent dialogue in Abuja, Nigeria on sexual and reproductive rights […]
